NRC Health (NRC) Operating Margin
- Operating margin · 12 months: Value 10.53%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 10.53% | Operating income / revenue. Period ending 2026-06-30. $14.74M ÷ $140.00M × 100 ≈ 10.53% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 14.74M USD | Operating Income (Loss) |
| Revenue | 140.00M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 63.08M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14.74M | $140.00M | (m) | (m) | $63.08M | 10.53% |
| 2026-03-31 | $19.56M | $138.64M | (m) | (m) | $57.87M | 14.11% |
| 2025-12-31 | $22.59M | $137.39M | (m) | (m) | $54.80M | 16.44% |
| 2025-09-30 | $27.51M | $139.10M | (m) | (m) | $51.81M | 19.78% |
| 2025-06-30 | $27.75M | $140.31M | (m) | (m) | $50.53M | 19.78% |
| 2025-03-31 | $35.03M | $141.30M | (m) | (m) | $44.02M | 24.79% |
| 2024-12-31 | $35.19M | $143.06M | (m) | (m) | $44.91M | 24.60% |
| 2024-09-30 | $37.31M | $144.16M | (m) | (m) | $44.53M | 25.89% |
| 2024-06-30 | $39.29M | $146.28M | (m) | (m) | $45.34M | 26.86% |
| 2024-03-31 | $39.79M | $147.42M | (m) | (m) | $46.09M | 26.99% |
| 2023-12-31 | $40.05M | $148.58M | (m) | (m) | $46.62M | 26.95% |
| 2023-09-30 | $40.58M | $148.72M | (m) | (m) | $46.09M | 27.28% |
| 2023-06-30 | $41.73M | $148.47M | (m) | (m) | $45.05M | 28.11% |
| 2023-03-31 | $43.86M | $149.60M | (m) | (m) | $43.83M | 29.32% |
| 2022-12-31 | $46.54M | $151.57M | (m) | (m) | $42.70M | 30.71% |
| 2022-09-30 | $47.17M | $151.72M | (m) | (m) | $42.06M | 31.09% |
| 2022-06-30 | $49.20M | $151.80M | (m) | (m) | $40.82M | 32.41% |
| 2022-03-31 | $49.95M | $150.93M | (m) | (m) | $40.09M | 33.09% |
| 2021-12-31 | $50.27M | $147.95M | (m) | (m) | $38.96M | 33.98% |
| 2021-09-30 | $47.58M | $144.43M | (m) | (m) | $37.95M | 32.95% |
| 2021-06-30 | $46.47M | $140.14M | (m) | (m) | $36.38M | 33.16% |
| 2021-03-31 | $43.50M | $134.88M | (m) | (m) | $35.21M | 32.25% |
| 2020-12-31 | $42.68M | $133.28M | (m) | (m) | $34.44M | 32.02% |
| 2020-09-30 | $44.45M | $131.13M | (m) | (m) | $33.80M | 33.90% |
| 2020-06-30 | $42.65M | $130.11M | (m) | (m) | $34.55M | 32.78% |
| 2020-03-31 | $43.52M | $130.36M | (m) | (m) | $34.02M | 33.39% |
| 2019-12-31 | $43.03M | $127.98M | (m) | (m) | $32.97M | 33.63% |
| 2019-09-30 | $40.47M | (m) | (m) | (m) | $32.62M | (m) |
| 2019-06-30 | $39.41M | (m) | (m) | (m) | $31.59M | (m) |
| 2019-03-31 | $37.02M | (m) | (m) | (m) | $31.21M | (m) |
| 2018-12-31 | $35.27M | $119.69M | (m) | (m) | $31.37M | 29.47% |
| 2018-09-30 | $34.54M | (m) | (m) | (m) | $31.15M | (m) |
| 2018-06-30 | $32.50M | (m) | (m) | (m) | $31.90M | (m) |
| 2018-03-31 | $33.19M | (m) | (m) | (m) | $30.87M | (m) |
| 2017-12-31 | $34.22M | $117.56M | (m) | (m) | $29.69M | 29.11% |
| 2017-09-30 | $34.39M | $116.03M | (m) | (m) | $28.64M | 29.64% |
| 2017-06-30 | $34.61M | $114.11M | (m) | (m) | $27.35M | 30.33% |
| 2017-03-31 | $33.17M | $111.79M | (m) | (m) | $27.71M | 29.68% |
| 2016-12-31 | $31.20M | $109.38M | (m) | (m) | $28.39M | 28.52% |
| 2016-09-30 | $30.07M | $107.38M | (m) | (m) | $28.06M | 28.00% |
| 2016-06-30 | $29.28M | $105.59M | (m) | (m) | $27.54M | 27.73% |
| 2016-03-31 | $28.62M | $103.94M | (m) | (m) | $26.91M | 27.54% |
| 2015-12-31 | $26.45M | $102.34M | (m) | (m) | $27.18M | 25.84% |
| 2015-09-30 | $25.16M | $101.10M | (m) | (m) | $27.75M | 24.88% |
| 2015-06-30 | $25.77M | $99.54M | (m) | (m) | $26.93M | 25.89% |
| 2015-03-31 | $25.73M | $99.08M | (m) | (m) | $26.28M | 25.96% |
| 2014-12-31 | $28.30M | $98.84M | (m) | (m) | $25.02M | 28.63% |
| 2014-09-30 | $27.90M | $96.64M | (m) | (m) | $24.46M | 28.88% |
| 2014-06-30 | $26.77M | $95.36M | (m) | (m) | $24.67M | 28.08% |
| 2014-03-31 | $25.99M | $93.71M | (m) | (m) | $25.08M | 27.73% |
| 2013-12-31 | $24.81M | $92.59M | (m) | (m) | $25.21M | 26.79% |
| 2013-09-30 | $24.55M | $91.66M | (m) | (m) | $24.90M | 26.79% |
| 2013-06-30 | $24.17M | $90.64M | (m) | (m) | $24.71M | 26.67% |
| 2013-03-31 | $23.85M | $88.92M | (m) | (m) | $23.88M | 26.83% |
| 2012-12-31 | $22.72M | $86.42M | (m) | (m) | $23.54M | 26.29% |
| 2012-09-30 | $21.95M | $83.54M | (m) | (m) | $23.19M | 26.28% |
| 2012-06-30 | $20.50M | $80.70M | (m) | (m) | $22.94M | 25.41% |
| 2012-03-31 | $19.12M | $78.38M | (m) | (m) | $23.36M | 24.39% |
| 2011-12-31 | $18.73M | $75.77M | (m) | (m) | $23.30M | 24.73% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $13.86M | $63.40M | (m) | (m) | $20.20M | 21.86% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $13.70M | $57.69M | (m) | (m) | $16.02M | 23.74% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |